Gravitate Health FHIR Implementation Guide, published by Gravitate Health Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/test-epi-composition/ and changes regularly. See the Directory of published versions
Full name:
Authorised dose form:
Legal status of supply:
Domain:
Resource status:
Product classification:
Document Details
Generated Narrative: Bundle TEST PURPOSES ONLY - sugammadex
Language: en
Profile: Bundle - ePI
Final Document at 2022-02-16 13:28:17+0000 by Organization ACME industry for Bundle: identifier = http://ema.europa.eu/identifier#None; type = document; timestamp = 2023-06-27 10:09:22+0000
Document Subject
Generated Narrative: MedicinalProductDefinition mp16018c8f310d03d6a566ded2f2a2880a
identifier: http://ema.europa.eu/identifier
/EU/1/23/1739/001
type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: Sugammadex Piramal 100 mg/mL solution for injection
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en
Document Content
Generated Narrative: Composition composition-en-16018c8f310d03d6a566ded2f2a2880a
Language: en
Profile: Composition (ePI)
identifier: http://ema.europa.eu/identifier
/EU/1/23/1739/001
status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - sugammadex
Mode | Time |
Official | 2022-02-16 13:28:17+0000 |
What is in this leaflet
What Sugammadex Piramal is Sugammadex Piramal contains the active substance sugammadex. Sugammadex Piramal is considered to be a selective relaxant binding agent since it only works with specific muscle relaxants, rocuronium bromide or vecuronium bromide.
What Sugammadex Piramal is used for
When you have some types of operations, your muscles must be completely relaxed. This makes it easier for the surgeon to do the operation. For this, the general anaesthetic you are given includes medicines to make your muscles relax. These are called muscle relaxants, and examples include rocuronium bromide and vecuronium bromide. Because these medicines also make your breathing muscles relax, you need help to breathe (artificial ventilation) during and after your operation until you can breathe on your own again. Sugammadex Piramal is used to speed up the recovery of your muscles after an operation to allow you to breathe on your own again earlier. It does this by combining with the rocuronium bromide or vecuronium bromide in your body. It can be used in adults whenever rocuronium bromide or vecuronium bromide is used and in children and adolescents (aged 2 to 17 years) when rocuronium bromide is used for a moderate level of relaxation.
You should not be given Sugammadex Piramal
Warnings and precautions
Talk to your anaesthetist before Sugammadex Piramal is given
Children and adolescents
This medicine is not recommended for infants less than 2 years of age.
Other medicines and Sugammadex Piramal
Tell your anaesthetist if you are taking, have recently taken or might take any other medicines. Sugammadex Piramal may affect other medicines or be affected by them.
Some medicines reduce the effect of Sugammadex Piramal
It is especially important that you tell your anaesthetist if you have recently taken:
Sugammadex Piramal can affect hormonal contraceptives
Sugammadex Piramal can make hormonal contraceptives - including the Pill , vaginal ring, implants or a hormonal Intra Uterine System (IUS) - less effective because it reduces how much you get of the progestogen hormone. The amount of progestogen lost by using Sugammadex Piramal is about the same as missing one oral contraceptive Pill. If you are taking the Pill on the same day as Sugammadex Piramal is given to you, follow the instructions for a missed dose in the Pill s package leaflet. If you are using other hormonal contraceptives (for example a vaginal ring, implant or IUS) you should use an additional non-hormonal contraceptive method (such as a condom) for the next 7 days and follow the advice in the package leaflet.
Effects on blood tests
In general, Sugammadex Piramal does not have an effect on laboratory tests. However, it may affect the results of a blood test for a hormone called progesterone. Talk to your doctor if your progesterone levels need to be tested on the same day you receive Sugammadex Piramal.
Pregnancy and breast-feeding
Tell your anaesthetist if you are pregnant or might be pregnant or if you are breast-feeding. You may still be given Sugammadex Piramal, but you need to discuss it first. It is not known whether sugammadex can pass into breast milk. Your anaesthetist will help you decide whether to stop breast-feeding, or whether to abstain from sugammadex therapy, considering the benefit of breast-feeding to the baby and the benefit of Sugammadex Piramal to the mother.
Driving and using machines
Sugammadex Piramal has no known influence on your ability to drive and use machines.
Sugammadex Piramal contains sodium
This medicine contains up to 9.7 mg sodium (main component of cooking / table salt) in each mL. This is equivalent to 0.5 % of the recommended maximum daily dietary intake of sodium for an adult.
Sugammadex Piramal will be given to you by your anaesthetist, or under the care of your anaesthetist.
The dose
Your anaesthetist will work out the dose of Sugammadex Piramal you need based on:
How Sugammadex Piramal is given
Sugammadex Piramal will be given to you by your anaesthetist. It is given as a single injection through an intravenous line.
If more Sugammadex Piramal is given to you than recommended
As your anaesthetist will be monitoring your condition carefully, it is unlikely that you will be given too much Sugammadex Piramal. But even if this happens, it is unlikely to cause any problems.
If you have any further questions on the use of this medicine, ask your anaesthetist or other doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them. If these side effects occur while you are under anaesthesia, they will be seen and treated by your anaesthetist.
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Not known (frequency cannot be estimated from the available data)
If you get any side effects, talk to your anaesthetist or other doctor. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system
listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Storage will be handled by healthcare professionals. Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton and on the label after EXP . The expiry date refers to the last day of that month.
Keep the vial in the outer carton in order to protect from light. After first opening and dilution, store at 2 to 8 C and use within 48 hours.
What Sugammadex Piramal contains
The active substance is sugammadex. 1 mL solution for injection contains sugammadex sodium equivalent to 100 mg sugammadex. Each vial of 2 mL contains sugammadex sodium equivalent to 200 mg sugammadex. Each vial of 5 mL contains sugammadex sodium equivalent to 500 mg sugammadex.
The other ingredients are water for injections, hydrochloric acid and/or sodium hydroxide (for pH adjustment). (see section 2 Sugammadex Piramal contains sodium).
What Sugammadex Piramal looks like and contents of the pack
Sugammadex Piramal is a clear and colourless to slightly yellow brown solution for injection. It comes in two different pack sizes, containing either 10 vials with 2 mL or 10 vials with 5 mL solution for injection. Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Piramal Critical Care B.V Rouboslaan 32, 2252 TR Voorschoten The Netherlands
This leaflet was last revised in June 2Detailed information on this medicine is available on the European Medicines Agency web site:
Entry 1 - fullUrl = Composition/composition-en-16018c8f310d03d6a566ded2f2a2880a
Resource Composition:
Generated Narrative: Composition composition-en-16018c8f310d03d6a566ded2f2a2880a
Language: en
Profile: Composition (ePI)
identifier:
http://ema.europa.eu/identifier
/EU/1/23/1739/001status: Final
type: Package Leaflet
category: Raw
date: 2022-02-16 13:28:17+0000
author: Organization ACME industry
title: TEST PURPOSES ONLY - sugammadex
Attesters
Mode Time Official 2022-02-16 13:28:17+0000
Entry 2 - fullUrl = MedicinalProductDefinition/mp16018c8f310d03d6a566ded2f2a2880a
Resource MedicinalProductDefinition:
Generated Narrative: MedicinalProductDefinition mp16018c8f310d03d6a566ded2f2a2880a
identifier:
http://ema.europa.eu/identifier
/EU/1/23/1739/001type: Medicinal Product
domain: Human use
status: active
legalStatusOfSupply: Medicinal product subject to medical prescription
name
productName: Sugammadex Piramal 100 mg/mL solution for injection
type: Full name
part
part: nan
type: Invented name part
part
part: nan
type: Scientific name part
part
part: nan
type: Strength part
part
part: nan
type: Pharmaceutical dose form part
Usages
Country Jurisdiction Language EU EU en